BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8089147)

  • 1. Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia.
    Nemere I; Dormanen MC; Hammond MW; Okamura WH; Norman AW
    J Biol Chem; 1994 Sep; 269(38):23750-6. PubMed ID: 8089147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 beta, 25 (OH)2-vitamin D3 is an antagonist of 1 alpha,25 (OH)2-vitamin D3 stimulated transcaltachia (the rapid hormonal stimulation of intestinal calcium transport).
    Norman AW; Nemere I; Muralidharan KR; Okamura WH
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1450-6. PubMed ID: 1336368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1 alpha,25(OH)2-vitamin D3 analog structure-function assessment of intestinal nuclear receptor occupancy with induction of calbindin-D28K.
    Zhou LX; Norman AW
    Endocrinology; 1995 Mar; 136(3):1145-52. PubMed ID: 7867568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).
    Zhou LX; Nemere I; Norman AW
    J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific binding of 24R,25-dihydroxyvitamin D3 to chick intestinal mucosa: 24R,25-dihydroxyvitamin D3 is an allosteric effector of 1,25-dihydroxyvitamin D3 binding.
    Wilhelm F; Ross FP; Norman AW
    Arch Biochem Biophys; 1986 Aug; 249(1):88-94. PubMed ID: 3017223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nongenomic effects of 1,25-dihydroxyvitamin D3: potential relation of a plasmalemmal receptor to the acute enhancement of intestinal calcium transport in chick.
    Nemere I
    J Nutr; 1995 Jun; 125(6 Suppl):1695S-1698S. PubMed ID: 7782929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.
    Dormanen MC; Bishop JE; Hammond MW; Okamura WH; Nemere I; Norman AW
    Biochem Biophys Res Commun; 1994 May; 201(1):394-401. PubMed ID: 8198601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens.
    Larsson B; Nemere I
    J Cell Biochem; 2003 Dec; 90(5):901-13. PubMed ID: 14624450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.
    Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
    Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
    Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
    Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent nonnuclear regulation of intestinal phosphate transport: effects of 1,25-dihydroxyvitamin D3,24,25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3.
    Nemere I
    Endocrinology; 1996 Jun; 137(6):2254-61. PubMed ID: 8641173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
    Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
    Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone down-regulates 1,25-dihydroxyvitamin D receptors (VDR) and VDR messenger ribonucleic acid in vitro and blocks homologous up-regulation of VDR in vivo.
    Reinhardt TA; Horst RL
    Endocrinology; 1990 Aug; 127(2):942-8. PubMed ID: 2164926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.